-
Serelaxin (brand name Reasanz;
developmental code name RLX-030) is a
medication which is
marketed in
Russia for the
treatment of
acute heart failure (AHF)...
- ISBN 978-0-8247-8465-2. DellaVecchia,
Matthew J. (December 2013). "Inaccurate
Serelaxin Chemical Structure".
Pharmacy and Therapeutics. 38 (12): 763. PMC 3875272...
- of
human relaxin-2 has been
developed as
investigational drug RLX030 (
serelaxin).[citation needed] It is
suggested that
relaxin could be used as a therapeutic...
-
Cloridarol C01DX16
Nicorandil C01DX18
Linsidomine C01DX19
Nesiritide C01DX21
Serelaxin C01DX22
Vericiguat C01DX51
Itramin tosilate,
combinations C01DX52 Prenylamine...
-
Myakala K,
Orlicky DJ,
Dobrinskikh E, Wang X, Levi M (August 2017). "
Serelaxin improves cardiac and
renal function in DOCA-salt
hypertensive rats". Scientific...
-
serazapine (INN) Serc
Serdaxin (Rexahn Pharmaceuticals)
serdemetan (INN)
serelaxin (INN)
Serentil Serevent serfibrate (INN)
sergliflozin (USAN) sergolexole...
-
Semparatide Teriparatide Agonists: Insulin-like
factor 3
Relaxin (1, 2, 3)
Serelaxin See here instead. See here instead. Agonists:
Azetirelin Fertirelin Montirelin...
-
Semparatide Teriparatide Agonists Insulin-like
factor 3
Relaxin (1, 2, 3)
Serelaxin Agonists Azetirelin JTP-2942
Montirelin Orotirelin Posatirelin Protirelin...
